Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta (Q45146790)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 November 2004
edit
Language Label Description Also known as
English
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta
scientific article published on 10 November 2004

    Statements

    Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta (English)
    Allen J Taylor
    Lance E Sullenberger
    Hyun J Lee
    Jeannie K Lee
    Karen A Grace
    10 November 2004
    3512-3517

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit